Breast cancer remains one of the most common cancers worldwide, and while modern medicine has made significant progress in diagnosis and treatment, many patients continue to seek complementary therapies to enhance their quality of life. One such therapy gaining attention is mistletoe extract therapy, a plant-based treatment that has been widely researched in Europe and is now being explored in India as well.
What is Mistletoe Therapy?
Mistletoe (Viscum album) is a semi-parasitic plant that has been used in complementary oncology for nearly a century, particularly in Germany and Switzerland. Extracts from the plant are formulated into injectable medicines and are administered under medical supervision. Unlike conventional chemotherapy or radiation, mistletoe therapy is not intended to directly destroy cancer cells but to support the body’s immune system and improve the patient’s overall well-being during cancer treatment.
How Mistletoe Helps Breast Cancer Patients
-
Immune System Support – Mistletoe extracts stimulate immune activity by enhancing the production of natural killer (NK) cells and T-cells, which play a role in fighting tumor cells.
-
Reduction of Side Effects – Clinical studies have shown that mistletoe therapy can help reduce common side effects of chemotherapy and radiation, such as fatigue, nausea, and loss of appetite.
-
Improved Quality of Life – Many patients report better sleep, improved mood, and reduced anxiety when using mistletoe therapy as part of their treatment plan.
-
Potential Tumor Control – Some research suggests mistletoe extracts may slow tumor growth or improve survival rates, though findings vary and more studies are ongoing.
Mistletoe Therapy in Combination with Standard Treatments
It is important to note that mistletoe is not a replacement for surgery, chemotherapy, or radiation. Instead, it is used as a complementary therapy alongside standard oncological treatments. Physicians trained in integrative oncology often recommend mistletoe injections to support patients throughout their cancer journey.
ABNOBA India: Bringing German Expertise to India
ABNOBA GmbH, based in Pforzheim, Germany, is a leading research-driven manufacturer of mistletoe preparations. Through ABNOBA India, these therapies are now available for patients seeking integrative cancer care. With decades of clinical experience and scientific research, ABNOBA’s formulations are designed to meet international safety and efficacy standards.
Conclusion
For breast cancer patients, mistletoe therapy offers a holistic approach that focuses not only on fighting the disease but also on enhancing the patient’s strength, resilience, and quality of life. With the growing presence of ABNOBA India, patients now have greater access to scientifically developed mistletoe preparations that are trusted by oncologists worldwide.
